Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci

Lung

Volumn 178, Issue 5, 2000, Pages 317-329

  Bouhafs, R K L ^a   Rauprich, P ^b   Herting, E ^b   Schroder A ^b   Robertson, B ^c   Jarstrand, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Group B streptococci; Lipid peroxidation; Oxygen radicals; Pulmonary surfactant

Indexed keywords

ALKENE DERIVATIVE; ALPHA TOCOPHEROL; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; MALONALDEHYDE; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; SURFACE TENSION;

ADULT; BIOLOGICAL PRODUCTS; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; REACTIVE OXYGEN SPECIES; STREPTOCOCCUS AGALACTIAE; SUPEROXIDES; TIME FACTORS; VITAMIN E;

EID: 0034537536     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000035     Document Type: Article

References (39)

1. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
2. Surfactant treatment of full-term newborns with respiratory failure
3. Oxygen-dependent microbial killing by phagocytes
4. The influence of vitamin E on human polymorphonuclear metabolism and function
5. Shock lung and diffuse alveolar damage. Pathological and pathogenic considerations
6. Lipid peroxidation of lung surfactant by bacteria in vitro
7. Phagocyte-induced lipid peroxidation of lung surfactant
8. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47 phox and p67 phox membrane translocation as the mechanism
9. Mechanisms of oxidant injury of cells
10. Surfactant therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial
11. Vitamin E decreases superoxide anion production by polymorphonuclear leukocytes
12. Exposure of hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties
13. Demonstration and characterization of buoyant-density subpopulations of group B streptococcus type III
14. Evidence of lung surfactant abnormality in respiratory failure: Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol
15. Tissue injury in inflammation. Oxidants, proteases and cationic proteins
16. Inhibitory effect of vitamins C and E on the oxygen free radical production in human polymorphonuclear leucocytes
17. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia
18. Incidence of neonatal infections with very low birth weight infants with severe RDS treated with a natural porcine surfactant
19. Experimental neonatal group B streptococcal pneumonia: Effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits
20. Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol
21. Surfactant therapy in full-term neonates with severe respiratory failure
22. Pulmonary surfactant
23. Alterations of the endogenous surfactant system in septic adult rats
24. Influence of peroxidation products of liposomal lipids on antibacterial activity of liposomes
25. Superoxide generation in leukocytes and vitamin E
26. The nitroblue tetrazolium (NBT) reduction of neutrophil granulocytes from newborn infants and their mothers in relation to the occurrence of bacteria in amnion fluid and cord blood
27. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS)
28. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro
29. Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro
30. Defective oxidative metabolic response of neutrophils from stressed neonates
31. Macrophages and polymorphonuclear neutrophils in lung defense and injury
32. Activation and activity of the superoxide generating system of neutrophils from human infants
33. Artificial surfactant (surfactant TA) modulates adherence and superoxide production of neutrophils
34. Neutrophils and the adult respiratory distress syndrome
35. Nitroblue tetrazolium (NBT) reduction by bacteria. Some properties of the reaction and its possible use
36. Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia
37. Surfactant and the pulmonary defense system
38. Inhibition of protein kinase C of human neutrophils by phosphatidylcholines